Kezar Life Sciences/$KZR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kezar Life Sciences
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Ticker
$KZR
Sector
Primary listing
Employees
9
Headquarters
Website
KZR Metrics
BasicAdvanced
$54m
-
-$6.17
-
-
Price and volume
Market cap
$54m
52-week high
$7.55
52-week low
$3.53
Average daily volume
143k
Financial strength
Current ratio
24.462
Quick ratio
23.979
Total debt to equity
2.076
Interest coverage (TTM)
-74.85%
Profitability
EBITDA (TTM)
-40.701
Management effectiveness
Return on assets (TTM)
-26.77%
Return on equity (TTM)
-53.75%
Valuation
Price to book
0.82
Price to tangible book (TTM)
0.82
Price to free cash flow (TTM)
-1.271
Free cash flow yield (TTM)
-78.70%
Free cash flow per share (TTM)
-5.737
Growth
Earnings per share change (TTM)
-42.73%
3-year earnings per share growth (CAGR)
-16.45%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs